Industry: Consumer Goods
Published Date: 2025-03-10
Pages: 86 Pages
Report ld: 3570296
Request Sample
Customized Report
HMO Formula Market Size(US$)

CAGR 2025-2031
11%
Market Size,2031
USD 7,856
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for HMO Formula was valued at US$ 3900 million in the year 2024 and is projected to reach a revised size of US$ 7856 million by 2031, growing at a CAGR of 11.0% during the forecast period.
HMO (Human Milk Oligosaccharides) formula milk refers to a specialized type of infant formula that incorporates oligosaccharides found naturally in human breast milk. These oligosaccharides are complex carbohydrates that serve various beneficial purposes, particularly for the infant’s digestive system and immune health. Breast milk is known to contain more than 200 different types of oligosaccharides, which play an important role in the development of the infant's gut microbiota, immunity, and overall health. Since these oligosaccharides are difficult to replicate, HMO formula has emerged as a substitute that mimics the benefits of breast milk, offering an advanced alternative for infants who may not have access to breastfeeding.
The primary purpose of HMO formula is to offer infants essential nutrients and bioactive components similar to those in breast milk. This includes providing support for immune defense, digestive health, and overall growth. The introduction of HMOs in infant formulas has revolutionized the infant nutrition market, offering a more scientific approach to supplementing breast milk for mothers who cannot breastfeed or who require additional support for their infants’ nutrition.
HMO formula milk typically comes in a range of variations to cater to specific infant needs. This includes:
Standard HMO formula: Aimed at healthy, full-term infants, providing all-around nutrition for growth and development.
Preterm and low birth weight HMO formula: Designed for premature or low birth weight infants, ensuring that their sensitive digestive systems receive the necessary support for optimal health.
Sensitive stomach HMO formula: Made for babies experiencing digestive discomforts like colic or reflux, this formula may contain additional components like probiotics or easier-to-digest proteins.
HMO formula with additional probiotics or nutrients: To support not just gut health but also immune development, these formulas combine HMOs with other beneficial ingredients such as probiotics, prebiotics, or DHA (docosahexaenoic acid).
The product is available in various forms such as powder, ready-to-feed liquid, and concentrated liquid, allowing parents to choose based on convenience and preference.
The market for HMO formula milk has experienced rapid growth due to several key factors. The growing awareness among parents of the critical role HMOs play in infant health has been a driving force. With increasing understanding of the benefits of HMOs in mimicking the bioactive components of breast milk, there is a rising demand for infant formulas that incorporate these oligosaccharides. As breastfeeding rates decline in some parts of the world, especially in urban areas, the demand for high-quality alternatives such as HMO formula milk has surged.
Market Opportunities: The emerging markets in Asia, Latin America, and the Middle East present significant growth opportunities for companies offering HMO-based formula milk. With rising disposable incomes and increased awareness of the importance of infant nutrition, these regions are expected to witness substantial demand for premium formula products. Innovations in production technologies, such as fermentation processes to create HMOs more efficiently, are also expected to make HMO-based formula more cost-effective, driving wider adoption across different demographics. Additionally, as more regulatory authorities approve the inclusion of HMOs in infant formula, companies have more opportunities to expand into new regions.
Market Risks: One of the major risks in the HMO formula market is the high production cost. The extraction and synthesis of HMOs remain an expensive and complex process, which can increase the price of the formula and limit its accessibility in price-sensitive markets. Regulatory challenges can also pose risks, as the approval of HMO inclusion in infant formula is still subject to different guidelines across regions. Furthermore, competition among major players in the market, including Abbott, Nestlé, Danone, and Mead Johnson, can limit market entry for smaller players, making it challenging for new companies to compete on price and innovation.
Market Concentration: The market is currently highly concentrated, with a few key players dominating the industry. Global giants like Abbott, Nestlé, Danone, and FrieslandCampina hold significant market share, primarily due to their established brand presence and distribution networks. This concentration of power limits opportunities for new entrants, although the growing consumer demand for HMO-based formula may attract smaller players looking to target niche segments of the market. However, as the market grows and diversifies, there may be room for more players to carve out a place.
Downstream Demand Trends: As consumer awareness about the benefits of HMO formula milk continues to rise, especially in developed markets, the demand for these formulas is expected to grow. Parents are increasingly looking for infant nutrition options that offer both convenience and nutritional superiority over traditional formulas. As breastfeeding rates are lower in some regions, particularly in developed countries, more parents are turning to HMO-based formulas to ensure their babies receive the best possible start in life. There is also a rising trend in seeking organic and clean-label formulas, which is likely to benefit the HMO formula segment as it is often marketed as a more natural and science-backed alternative to traditional formula milk.
Latest Technologies: The use of biotechnology in HMO production has been a major advancement in the field of infant nutrition. Companies are leveraging fermentation-based techniques to produce HMOs more efficiently and cost-effectively. These advances have the potential to reduce the cost of HMO formula milk, making it more accessible to a broader market. Additionally, the incorporation of other beneficial ingredients, such as prebiotics, probiotics, and DHA, alongside HMOs, is gaining traction as part of the latest innovations in the industry. These ingredients work synergistically to support the infant’s immune system, digestive health, and overall development.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for HMO Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMO Formula.
The HMO Formula market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HMO Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HMO Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Abbott
Mead Johnson (Reckitt)
Nestlé
Danone
FrieslandCampina(Friso)
Yili Group
Segment by Type
Powder
Liquid
Segment by Application
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HMO Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HMO Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 HMO Formula Market Overview
1.1 Product Definition
1.2 HMO Formula by Type
1.2.1 Global HMO Formula Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 HMO Formula by Application
1.3.1 Global HMO Formula Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global HMO Formula Market Size Estimates and Forecasts
1.4.1 Global HMO Formula Revenue 2020-2031
1.4.2 Global HMO Formula Sales 2020-2031
1.4.3 Global HMO Formula Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HMO Formula Market Competition by Manufacturers
2.1 Global HMO Formula Sales Market Share by Manufacturers (2020-2025)
2.2 Global HMO Formula Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HMO Formula Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HMO Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HMO Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HMO Formula, Product Type & Application
2.7 Global Key Manufacturers of HMO Formula, Date of Enter into This Industry
2.8 Global HMO Formula Market Competitive Situation and Trends
2.8.1 Global HMO Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HMO Formula Players Market Share by Revenue
2.8.3 Global HMO Formula Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HMO Formula Market Scenario by Region
3.1 Global HMO Formula Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HMO Formula Sales by Region: 2020-2031
3.2.1 Global HMO Formula Sales by Region: 2020-2025
3.2.2 Global HMO Formula Sales by Region: 2026-2031
3.3 Global HMO Formula Revenue by Region: 2020-2031
3.3.1 Global HMO Formula Revenue by Region: 2020-2025
3.3.2 Global HMO Formula Revenue by Region: 2026-2031
3.4 North America HMO Formula Market Facts & Figures by Country
3.4.1 North America HMO Formula Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HMO Formula Sales by Country (2020-2031)
3.4.3 North America HMO Formula Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HMO Formula Market Facts & Figures by Country
3.5.1 Europe HMO Formula Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HMO Formula Sales by Country (2020-2031)
3.5.3 Europe HMO Formula Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HMO Formula Market Facts & Figures by Region
3.6.1 Asia Pacific HMO Formula Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HMO Formula Sales by Region (2020-2031)
3.6.3 Asia Pacific HMO Formula Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HMO Formula Market Facts & Figures by Country
3.7.1 Latin America HMO Formula Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HMO Formula Sales by Country (2020-2031)
3.7.3 Latin America HMO Formula Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HMO Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa HMO Formula Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HMO Formula Sales by Country (2020-2031)
3.8.3 Middle East and Africa HMO Formula Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HMO Formula Sales by Type (2020-2031)
4.1.1 Global HMO Formula Sales by Type (2020-2025)
4.1.2 Global HMO Formula Sales by Type (2026-2031)
4.1.3 Global HMO Formula Sales Market Share by Type (2020-2031)
4.2 Global HMO Formula Revenue by Type (2020-2031)
4.2.1 Global HMO Formula Revenue by Type (2020-2025)
4.2.2 Global HMO Formula Revenue by Type (2026-2031)
4.2.3 Global HMO Formula Revenue Market Share by Type (2020-2031)
4.3 Global HMO Formula Price by Type (2020-2031)
5 Segment by Application
5.1 Global HMO Formula Sales by Application (2020-2031)
5.1.1 Global HMO Formula Sales by Application (2020-2025)
5.1.2 Global HMO Formula Sales by Application (2026-2031)
5.1.3 Global HMO Formula Sales Market Share by Application (2020-2031)
5.2 Global HMO Formula Revenue by Application (2020-2031)
5.2.1 Global HMO Formula Revenue by Application (2020-2025)
5.2.2 Global HMO Formula Revenue by Application (2026-2031)
5.2.3 Global HMO Formula Revenue Market Share by Application (2020-2031)
5.3 Global HMO Formula Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott HMO Formula Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Mead Johnson (Reckitt)
6.2.1 Mead Johnson (Reckitt) Company Information
6.2.2 Mead Johnson (Reckitt) Description and Business Overview
6.2.3 Mead Johnson (Reckitt) HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mead Johnson (Reckitt) HMO Formula Product Portfolio
6.2.5 Mead Johnson (Reckitt) Recent Developments/Updates
6.3 Nestlé
6.3.1 Nestlé Company Information
6.3.2 Nestlé Description and Business Overview
6.3.3 Nestlé HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nestlé HMO Formula Product Portfolio
6.3.5 Nestlé Recent Developments/Updates
6.4 Danone
6.4.1 Danone Company Information
6.4.2 Danone Description and Business Overview
6.4.3 Danone HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Danone HMO Formula Product Portfolio
6.4.5 Danone Recent Developments/Updates
6.5 FrieslandCampina(Friso)
6.5.1 FrieslandCampina(Friso) Company Information
6.5.2 FrieslandCampina(Friso) Description and Business Overview
6.5.3 FrieslandCampina(Friso) HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FrieslandCampina(Friso) HMO Formula Product Portfolio
6.5.5 FrieslandCampina(Friso) Recent Developments/Updates
6.6 Yili Group
6.6.1 Yili Group Company Information
6.6.2 Yili Group Description and Business Overview
6.6.3 Yili Group HMO Formula Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Yili Group HMO Formula Product Portfolio
6.6.5 Yili Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HMO Formula Industry Chain Analysis
7.2 HMO Formula Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HMO Formula Production Mode & Process Analysis
7.4 HMO Formula Sales and Marketing
7.4.1 HMO Formula Sales Channels
7.4.2 HMO Formula Distributors
7.5 HMO Formula Customer Analysis
8 HMO Formula Market Dynamics
8.1 HMO Formula Industry Trends
8.2 HMO Formula Market Drivers
8.3 HMO Formula Market Challenges
8.4 HMO Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global HMO Formula market is projected to grow from US$ 4200 million in 2025 to US$ 8633 million by 2032, at a CAGR of 11.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 136
USD 4900.00
(Single User License)
The global HMO Formula market size was US$ 4200 million in 2025 and is forecast to reach a readjusted size of US$ 8633 million by 2032 with a CAGR of 11.0% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 80
USD 4250.00
(Single User License)
The global market for HMO Formula was estimated to be worth US$ 4200 million in 2025 and is projected to reach US$ 8633 million, growing at a CAGR of 11.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 107
USD 3950.00
(Single User License)
The global HMO Formula market was valued at US$ 4200 million in 2025 and is anticipated to reach US$ 8633 million by 2032, at a CAGR of 11.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 110
USD 2900.00
(Single User License)
The global HMO Formula market is projected to grow from US$ 3900 million in 2024 to US$ 7856 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-02
Pages: 146
USD 4900.00
(Single User License)
The global market for HMO Formula was estimated to be worth US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 100
USD 3950.00
(Single User License)
The global HMO Formula market size was US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 77
USD 4250.00
(Single User License)
The global HMO Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 93
USD 2900.00
(Single User License)
The global market for HMO Formula was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 124
USD 3950.00
(Single User License)
The global HMO Formula market is projected to grow from US$ 4200 million in 2025 to US$ 8633 million by 2032, at a CAGR of 11.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 136
The global HMO Formula market size was US$ 4200 million in 2025 and is forecast to reach a readjusted size of US$ 8633 million by 2032 with a CAGR of 11.0% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 80
The global market for HMO Formula was estimated to be worth US$ 4200 million in 2025 and is projected to reach US$ 8633 million, growing at a CAGR of 11.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 107
The global HMO Formula market was valued at US$ 4200 million in 2025 and is anticipated to reach US$ 8633 million by 2032, at a CAGR of 11.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 110
The global HMO Formula market is projected to grow from US$ 3900 million in 2024 to US$ 7856 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-02
Pages: 146
The global market for HMO Formula was estimated to be worth US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 100
The global HMO Formula market size was US$ 3900 million in 2024 and is forecast to a readjusted size of US$ 7856 million by 2031 with a CAGR of 11.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 77
The global HMO Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 93
The global market for HMO Formula was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 124
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now